apomorphine has been researched along with mdl 28133a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humphreys, TM; Schmidt, CJ; Sorensen, SM; Taylor, VL | 1 |
| Brown, D; Byrd, G; Feldman, DJ; Flannery, R; Frank, RA; Kehne, JH; Shah, S; Soni, S | 1 |
2 other study(ies) available for apomorphine and mdl 28133a
| Article | Year |
|---|---|
5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
Topics: Action Potentials; Amphetamines; Animals; Apomorphine; Carbidopa; Dopamine; Dopamine Antagonists; Fenclonine; Levodopa; Male; Neurons; Piperidines; Rats; Rats, Inbred Strains; Ritanserin | 1992 |
Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Fluorobenzenes; Male; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereotyped Behavior | 1997 |